"Designing Growth Strategies is in our DNA"

U.K. Healthcare Consulting Market Size, Share & COVID-19 Impact Analysis, By Service Type (Healthcare IT Solutions, Marketing & Sales, Human Resources, Finance, Operations & General Management, Strategic Management, Business Analytics, and Others), By End User (Healthcare Providers, Healthcare Payers, Biopharmaceutical Companies, and Others), and Country Forecast, 2023-2030

Last Updated: November 24, 2025 | Format: PDF | Report ID: FBI108682

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Overview of Healthcare IT Infrastructure
    2. Snapshot of Venture Capital Investments
    3. Overview of U.K. Hospital Infrastructure
    4. Verticals in Healthcare IT Consulting
    5. Trends in U.K. Healthcare Workforce
    6. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    7. Impact of COVID-19 on the U.K. Market
  5. U.K. Healthcare Consulting Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Healthcare IT Solutions
      2. Marketing & Sales
      3. Human Resources
      4. Finance, Operations & General Management
      5. Strategic Management
      6. Business Analytics
      7. Others
    2. Market Analysis, Insights and Forecast – By End User
      1. Healthcare Providers
      2. Healthcare Payers
      3. Biopharmaceutical Companies
      4. Others
  6. Competitive Analysis
    1. U.K. Market Share Analysis (2022)
    2. Company Profiles
      1. Accenture
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. International Business Machines Corporation (IBM)
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Deloitte Touche Tohmatsu Limited
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Bain & Company, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. HCL Technologies Limited
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Cognizant
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Microsoft
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Capgemini
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Atos SE
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. CGI Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      11. Fujitsu
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Overview of Healthcare IT Infrastructure
    2. Snapshot of Venture Capital Investments
    3. Overview of U.K. Hospital Infrastructure
    4. Verticals in Healthcare IT Consulting
    5. Trends in U.K. Healthcare Workforce
    6. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    7. Impact of COVID-19 on the U.K. Market
  5. U.K. Healthcare Consulting Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Healthcare IT Solutions
      2. Marketing & Sales
      3. Human Resources
      4. Finance, Operations & General Management
      5. Strategic Management
      6. Business Analytics
      7. Others
    2. Market Analysis, Insights and Forecast – By End User
      1. Healthcare Providers
      2. Healthcare Payers
      3. Biopharmaceutical Companies
      4. Others
  6. Competitive Analysis
    1. U.K. Market Share Analysis (2022)
    2. Company Profiles
      1. Accenture
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. International Business Machines Corporation (IBM)
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Deloitte Touche Tohmatsu Limited
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Bain & Company, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. HCL Technologies Limited
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Cognizant
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Microsoft
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Capgemini
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Atos SE
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. CGI Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      11. Fujitsu
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1:  U.K. Healthcare Consulting Market Revenue Breakdown (USD billion, %) by Service Type, 2022 & 2030

Figure 2:  U.K. Healthcare Consulting Market Value Share (%), by Service Type, 2022 & 2030

Figure 3:  U.K. Healthcare Consulting Market Value Share (%), by End User, 2022 & 2030

Figure 4:  U.K. Healthcare Consulting Market Share (%), By Company, 2022

Table 1:  U.K. Healthcare Consulting Market Revenue (USD billion) Forecast, by Service Type, 2019–2030

Table 2:  U.K. Healthcare Consulting Market Revenue (USD billion) Forecast, by End User, 2019–2030

  • 2019-2030
  • 2022
  • 2019-2021
  • 101
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann